Updates on the use of vaccines in dermatological conditions.
作者： Mazen Kurban , Edith Hanna , Mohammed Dany , Ossama Abbas , Firas Kreidieh
DOI: 10.4103/IJDVL.IJDVL_1036_16
关键词: Intensive care medicine 、 Medicine 、 Dermatological diseases 、 Original research 、 Dermatologic diseases
摘要: Numerous vaccines are being actively developed for use in dermatologic diseases. Advances the fields of immunotherapy, genetics and molecular medicine have allowed design prophylactic therapeutic with immense potential managing infections malignancies skin. This review addresses different available dermatological diseases those under development future use. The major limitation our is its complete reliance on published data. Our strictly limited to availability research online through databases. We do not cite any authors' previous publications nor we conducted original studies regarding dermatology. Strength would been added paper had by team candidate delineated paper.
ijdvl.com
sci-hub.st 参考文章(117)
Naohiro Seo, Fukumi Furukawa, Yoshiki Tokura, Masahiro Takigawa, Vaccine therapy for cutaneous T-cell lymphoma Hematology-oncology Clinics of North America. ,vol. 17, pp. 1467- 1474 ,(2003) , 10.1016/S0889-8588(03)00113-8
M. Skoberne, R. Cardin, A. Lee, A. Kazimirova, V. Zielinski, D. Garvie, A. Lundberg, S. Larson, F. J. Bravo, D. I. Bernstein, J. B. Flechtner, D. Long, An Adjuvanted Herpes Simplex Virus 2 Subunit Vaccine Elicits a T Cell Response in Mice and Is an Effective Therapeutic Vaccine in Guinea Pigs Journal of Virology. ,vol. 87, pp. 3930- 3942 ,(2013) , 10.1128/JVI.02745-12
F M Cowan, R S French, P Mayaud, R Gopal, N J Robinson, S A. de Oliveira, T Faillace, A Uuskula, M Nygard-Kibur, S Ramalingam, G Sridharan, R El Aouad, K Alami, M Rbai, N P Sunil-Chandra, D W Brown, Seroepidemiological study of herpes simplex virus types 1 and 2 in Brazil, Estonia, India, Morocco, and Sri Lanka Sexually Transmitted Infections. ,vol. 79, pp. 286- 290 ,(2003) , 10.1136/STI.79.4.286
Ronald D. Alvarez, Warner K. Huh, Sejong Bae, Lawrence S. Lamb, Michael G. Conner, Jean Boyer, Chenguang Wang, Chien-Fu Hung, Elizabeth Sauter, Mihaela Paradis, Emily A. Adams, Shirley Hester, Bradford E. Jackson, T.C. Wu, Cornelia L. Trimble, A pilot study of pNGVL4a-CRT/E7(detox) for the treatment of patients with HPV16 + cervical intraepithelial neoplasia 2/3 (CIN2/3) Gynecologic Oncology. ,vol. 140, pp. 245- 252 ,(2016) , 10.1016/J.YGYNO.2015.11.026
P. E. CASTLE, M. MAZA, Prophylactic HPV vaccination: past, present, and future. Epidemiology and Infection. ,vol. 144, pp. 449- 468 ,(2016) , 10.1017/S0950268815002198
Stephen J. Cook, Dennis K. Flaherty, Review of the Persistence of Herpes Zoster Vaccine Efficacy in Clinical Trials Clinical Therapeutics. ,vol. 37, pp. 2388- 2397 ,(2015) , 10.1016/J.CLINTHERA.2015.09.019
Mohammed K Ali, Lindsay M Jaacks, Alysse J Kowalski, Karen R Siegel, Majid Ezzati, None, Noncommunicable Diseases: Three Decades Of Global Data Show A Mixture Of Increases And Decreases In Mortality Rates Health Affairs. ,vol. 34, pp. 1444- 1455 ,(2015) , 10.1377/HLTHAFF.2015.0570
M. N. Oxman, K. E. Schmader, Editorial Commentary: Zoster Vaccine in Immunocompromised Patients: Time to Reconsider Current Recommendations Clinical Infectious Diseases. ,vol. 59, pp. 920- 922 ,(2014) , 10.1093/CID/CIU501
So Youn Shin, Recent update in HIV vaccine development Clinical and Experimental Vaccine Research. ,vol. 5, pp. 6- 11 ,(2016) , 10.7774/CEVR.2016.5.1.6
Lisa H. Butterfield, Lessons learned from cancer vaccine trials and target antigen choice. Cancer Immunology, Immunotherapy. ,vol. 65, pp. 805- 812 ,(2016) , 10.1007/S00262-016-1801-1